Umeclidinium 62.5mcg, vilanterol 25mcg; per ­inhalation; dry pwd for oral inhalation. LABA as monotherapy (without ICS) for asthma can increase risk of asthma-related events. Do not initiate in ...

Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. (NASDAQ: INVA), today announced that positive results from the Phase 3 oral zoliflodacin trial will be highlighted in an oral ...

Big pharmaceuticals companies are expected to unveil lots of promising drug therapies in 2015 - specifically drugs that could make billions in sales within five years. Big pharmaceuticals ...

Panoro Energy has signed an agreement with the Government of Equatorial Guinea on the key terms for the award of offshore ...

GSK plc. GSK will report first-quarter 2024 results on May 1, before the opening bell. In the last reported quarter, the ...

AstraZeneca (AZ), GlaxoSmithKline (GSK), Sanofi, Allergan and Britannia Pharma have been reprimanded for running advertisements that breached the Association of British Pharmaceutical Industry ...